Skip to content
OpenCapital
Get started

Enanta Pharmaceuticals ENTA Q1 2026 earnings

Reported May 11, 2026 · Before market open

Revenue$17.2MBeat by $131.7K
EPS-$0.45Beat by $0.01
Revenue estimate$17.0M
EPS estimate-$0.46

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$16.8M
EPS estimate-$0.51

Versus estimates

Revenue

Q1 2026$17.2MBeat by $131.7K
Q4 2025$18.6MBeat by $2.7MQ3 2025$15.1MMiss by $845.6KQ2 2025$18.3MBeat by $2.3MQ1 2025$14.9MMiss by $1.0MQ4 2024$17.0MMiss by $290.3K

Diluted EPS

Q1 2026-$0.45Beat by $0.01
Q4 2025-$0.42Beat by $0.12Q3 2025-$0.87Beat by $0.26Q2 2025-$0.85Beat by $0.40Q1 2025-$1.06Miss by $0.02Q4 2024-$1.05Beat by $0.11

Ask the moment Enanta Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Enanta Pharmaceuticals report Q1 2026 earnings?
Enanta Pharmaceuticals (ENTA) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Enanta Pharmaceuticals's Q1 2026 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $17.2M and eps of $-0.45 for Q1 2026.
Did Enanta Pharmaceuticals beat estimates in Q1 2026?
Revenue beat the consensus estimate of $17.0M by $131.7K. EPS beat the consensus estimate of $-0.46 by $0.01.
How did Enanta Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.0% from $14.9M a year earlier and eps grew 57.5% from $-1.06.
Where can I find Enanta Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-216735) and the 10-Q periodic report (0001193125-26-220572) directly on SEC EDGAR. The filing index links above go to sec.gov.